A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent

Inclusion Criteria: * Participant must be of Japanese descent (both biological parents are ethnically Japanese). * In the opinion of the investigator, is a healthy participant, without any clinically significant abnormalities in their medical history, physical examination, ECGs, or clinical laboratory assessments determinations. * Women should be of non-childbearing potential. Exclusion Criteria: * Any significant acute or chronic medical illness. * Current or recent (within 3 months of study drug administration) gastrointestinal disease that could impact upon the absorption of study drug. * Any major surgery within 90 days of study drug administration. Other protocol-defined inclusion/exclusion criteria apply.